Implant decontamination during surgical peri‐implantitis treatment: a randomized, double‐blind, placebo‐controlled trial

Abstract

Implant surface decontamination with 0.12% CHX + 0.05% CPC in resective surgical treatment of peri-implantitis leads to a greater immediate suppression of anaerobic bacteria on the implant surface than a placebo-solution, but does not lead to superior clinical results. The long-term microbiological effect remains unknown.

Peri-implant Diseases

“…97 The management of peri-implantitis can be divided into (1) nonsurgical management and (2) surgical management; surgical management encompass resective and regenerative treatment. [97][98][99][100] However, there is lack of standardized treatment protocols for peri-implant disease. The following text comprehensively reviews the different therapeutic protocols that have been proposed for the management of peri-implant diseases.…”

Treatment of Peri-Implantitis and the Failing Implant

“…Although chlorhexidine is described in the CIST protocol, 69 the most effective treatment to detoxify the implant surface has not been identified. 73 Many other surface treatments aimed at eradication of the biofilm have been described [73][74][75][76][77][78] ; these include EDTA, citric acid, hydrogen peroxide, local anesthetic, cetylpyridinium chloride, and tetracycline, among others. Mechanical debridement alone, as described in protocol A, is considered to be inadequate for this group of lesions as a result of the increased pocket depth, thus necessitating the effort at antisepsis.…”

Corrigendum

“…After investigating the details of the matter, and receiving written confirmation from the authors that what is mentioned in the corrigendum is the entire body of conflicts of interest, I have decided to publish the corrigendum (de Waal et al 2014).…”